Amgen Inc Drug Patent Portfolio

Amgen Inc's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Amgen Inc News

Amgen Acquires Cancer Treatment Company Dark Blue for $840 Million - Bloomberg.com

06 Jan, 2026

5 Major Pharmaceutical Stocks Likely to Excel in 2026 - TradingView

23 Dec, 2025

Novo Nordisk or Amgen: Which Healthcare Investment Is the Better Option?

23 Dec, 2025

Trump poised to reveal major agreements with pharmaceutical companies aimed at reducing medication costs - KATU

19 Dec, 2025

See More